NEW YORK (TheStreet) -- Shares of Albemarle (ALB - Get Report) were falling 11.8 % to $48.83 Thursday after the chemical company missed analysts' estimates for earnings and revenue for the fourth quarter.
Albemarle reported earnings of 99 cents a share for the fourth quarter, missing analysts' estimates of $1.03 a share. Revenue fell 6.4% year over year to $598.57 million for the quarter, below analysts' estimates of $639.05 million.
"Our fourth quarter financial results, driven by strong Catalyst Solutions performance, allowed us to deliver 5% adjusted earnings per share growth in 2014 - well within the range of our guidance," president and CEO Luke Kissam said in a statement. "In addition, we closed the Rockwood acquisition in early January and have already captured approximately $30 million in annualized synergies, which is in line with our expectations."
Exclusive Report: Jim Cramer's Best Stocks for 2015
TheStreet Ratings team rates ALBEMARLE CORP as a Buy with a ratings score of B. TheStreet Ratings Team has this to say about their recommendation:
"We rate ALBEMARLE CORP (ALB) a BUY. This is driven by a few notable strengths, which we believe should have a greater impact than any weaknesses, and should give investors a better performance opportunity than most stocks we cover. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, reasonable valuation levels and expanding profit margins. We feel these strengths outweigh the fact that the company has had sub par growth in net income."
You can view the full analysis from the report here: ALB Ratings Report